185 related articles for article (PubMed ID: 17376040)
61. Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up.
Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Brzozowski T; Konturek SJ; Korolczuk A
J Physiol Pharmacol; 2014 Feb; 65(1):75-82. PubMed ID: 24622832
[TBL] [Abstract][Full Text] [Related]
62. Dietary lipids and NAFLD: suggestions for improved nutrition.
Molendi-Coste O; Legry V; Leclercq IA
Acta Gastroenterol Belg; 2010; 73(4):431-6. PubMed ID: 21299150
[TBL] [Abstract][Full Text] [Related]
63. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.
Loguercio C; De Girolamo V; de Sio I; Tuccillo C; Ascione A; Baldi F; Budillon G; Cimino L; Di Carlo A; Di Marino MP; Morisco F; Picciotto F; Terracciano L; Vecchione R; Verde V; Del Vecchio Blanco C
J Hepatol; 2001 Nov; 35(5):568-74. PubMed ID: 11690701
[TBL] [Abstract][Full Text] [Related]
64. [Research on the relationship between non-alcoholic fatty liver disease and platelet phospholipid fatty acids].
Yu XM; Li D; Xie HB; Wang Q; Xu AM; Bi QH; Ye XW; Fan FH
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):225-6. PubMed ID: 19335990
[No Abstract] [Full Text] [Related]
65. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.
Parnell JA; Raman M; Rioux KP; Reimer RA
Liver Int; 2012 May; 32(5):701-11. PubMed ID: 22221818
[TBL] [Abstract][Full Text] [Related]
66. Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis.
Moya D; Baker SS; Liu W; Garrick M; Kozielski R; Baker RD; Zhu L
Clin Nutr; 2015 Jun; 34(3):549-56. PubMed ID: 25000850
[TBL] [Abstract][Full Text] [Related]
67. Experimental observations and clinical implications of fasting and diet supplementation in fatty livers.
Grattagliano I; Portincasa P; Caraceni P; Palmieri VO; Domenicali M; Bernardi M; Palasciano G
Eur Rev Med Pharmacol Sci; 2003; 7(1):1-7. PubMed ID: 12908728
[TBL] [Abstract][Full Text] [Related]
68. Iron status in obesity: An independent association with metabolic parameters and effect of weight loss.
Guglielmi V; D'Adamo M; Bellia A; Ciotto RT; Federici M; Lauro D; Sbraccia P
Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):541-7. PubMed ID: 25843660
[TBL] [Abstract][Full Text] [Related]
69. Iron and insulin resistance.
Fargion S; Dongiovanni P; Guzzo A; Colombo S; Valenti L; Fracanzani AL
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():61-3. PubMed ID: 16225476
[TBL] [Abstract][Full Text] [Related]
70. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.
Sumida Y; Nakashima T; Yoh T; Furutani M; Hirohama A; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2003 Jan; 38(1):32-8. PubMed ID: 12480557
[TBL] [Abstract][Full Text] [Related]
71. The effect of lifestyle changes in non-alcoholic fatty liver disease.
Centis E; Marzocchi R; Di Domizio S; Ciaravella MF; Marchesini G
Dig Dis; 2010; 28(1):267-73. PubMed ID: 20460922
[TBL] [Abstract][Full Text] [Related]
72. Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease.
Takahashi A; Abe K; Usami K; Imaizumi H; Hayashi M; Okai K; Kanno Y; Tanji N; Watanabe H; Ohira H
Int J Sports Med; 2015 Oct; 36(10):848-52. PubMed ID: 26090879
[TBL] [Abstract][Full Text] [Related]
73. Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease.
Fujita K; Nozaki Y; Wada K; Yoneda M; Endo H; Takahashi H; Iwasaki T; Inamori M; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nagashima Y; Nakajima A
Gut; 2008 Nov; 57(11):1583-91. PubMed ID: 18596193
[TBL] [Abstract][Full Text] [Related]
74. The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis.
Akin K; Beyler AR; Kaya M; Erden E
Turk J Gastroenterol; 2003 Dec; 14(4):228-33. PubMed ID: 15048596
[TBL] [Abstract][Full Text] [Related]
75. Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?
Finelli C; Tarantino G
J Gastrointestin Liver Dis; 2012 Sep; 21(3):293-302. PubMed ID: 23012671
[TBL] [Abstract][Full Text] [Related]
76. Phenotyping the effect of diet on non-alcoholic fatty liver disease.
de Wit NJ; Afman LA; Mensink M; Müller M
J Hepatol; 2012 Dec; 57(6):1370-3. PubMed ID: 22796155
[TBL] [Abstract][Full Text] [Related]
77. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease.
Kojima H; Sakurai S; Uemura M; Takekawa T; Morimoto H; Tamagawa Y; Fukui H
Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):259S-63S. PubMed ID: 16385233
[TBL] [Abstract][Full Text] [Related]
78. [Non-alcoholic fatty liver].
Zwimpfer J
Praxis (Bern 1994); 2000 Oct; 89(43):1757-8. PubMed ID: 11103621
[No Abstract] [Full Text] [Related]
79. A high-fat and cholesterol diet causes fatty liver in guinea pigs. The role of iron and oxidative damage.
Ye P; Cheah IK; Halliwell B
Free Radic Res; 2013 Aug; 47(8):602-13. PubMed ID: 23692125
[TBL] [Abstract][Full Text] [Related]
80. Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome.
Zimmermann A; Zimmermann T; Schattenberg J; Pöttgen S; Lotz J; Rossmann H; Roeddiger R; Biesterfeld S; Geiss HC; Schuchmann M; Galle PR; Weber MM
Eur J Intern Med; 2011 Jun; 22(3):305-10. PubMed ID: 21570653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
